- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Senores Pharmaceuticals Limited has submitted its annual disclosure regarding share encumbrance by the Promoter and Promoter Group for the financial year ending March 31, 2025. This disclosure aims to enhance transparency concerning the company's financial stability and ownership structure, which is important for stakeholders assessing potential impacts on shareholder equity.